Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$27.31M-0.4%-$39.23M-30.6%-$39.58M+28.8%-$31.17M+42.9%-$27.21M+57.6%
$589K-20.5%$626K-15.9%$693K-7.0%$712K-1.0%$741K+9.8%
$9.98M+67.1%$9.13M+67.8%$8.63M+81.9%$6.59M+82.0%$5.98M+148%
-$19.99M+42.0%-$18.01M+55.9%-$21.24M+52.1%-$28.37M+48.5%-$34.48M+32.3%
$1.03M+59.7%
-$993K+37.2%
$63.46M+42.6%$30.76M-18.9%$33.48M-4.3%$39.22M-43.5%$44.5M-10.7%
$10.01M$9.03M
-$20.3M+42.8%-$18.93M+54.0%-$22.16M+50.7%-$29.25M+47.6%-$35.51M+31.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does TriSalus Life Sciences, Inc. generate?
TriSalus Life Sciences, Inc. (TLSI) generated -$20.0M in operating cash flow over the trailing twelve months.
What is TriSalus Life Sciences, Inc.'s free cash flow?
After $1.2M of capital expenditures, TriSalus Life Sciences, Inc.'s free cash flow was -$20.3M over the trailing twelve months, up 42.8% year over year.
Where does TriSalus Life Sciences, Inc.'s cash flow data come from?
Every line is extracted from TriSalus Life Sciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.